What is TAKHZYRO?
TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older.
It is not known if TAKHZYRO is safe and effective in children under 2 years of age.
IMPORTANT SAFETY INFORMATION
TAKHZYRO may cause serious side effects, including allergic reactions.
Call your healthcare provider or get emergency help right away if you have any of the following symptoms:
- difficulty breathing
- chest tightness
- fast heartbeat
The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, headache, rash, dizziness, diarrhea, and muscle aches.
These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to FDA at 1-800-FDA-1088.
TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.
Please see full Prescribing Information, including information for patients.